Pancreatectomy Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Pancreatectomy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

PancreatectomyPancreas NeoplasmCyst of Pancreas
Case Comprehensive Cancer Center234 enrolled1 locationNCT05720338
Recruiting
Not Applicable

Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty

Complication of Surgical ProcedurePancreatectomy
Assistance Publique - Hôpitaux de Paris150 enrolled1 locationNCT05992857
Recruiting
Not Applicable

Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)

SurgeryPancreatic NeoplasmsPancreatic Cyst+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)256 enrolled1 locationNCT06939023
Recruiting

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

Pancreatic Cancer ResectablePancreatectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)94 enrolled10 locationsNCT07157605
Recruiting
Not Applicable

Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study

Pancreatic Cancer, AdultCephalic Duodenopancreatectomy
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud20 enrolled1 locationNCT06852014
Recruiting

A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

Chemotherapy EffectLocally Advanced Pancreatic CancerPancreatectomy+1 more
Oslo University Hospital400 enrolled5 locationsNCT06944587
Recruiting

Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy

Enhanced Recovery After SurgeryPancreatic Cancer ResectablePancreatectomy
University of Thessaly170 enrolled1 locationNCT06935448
Recruiting
Phase 3

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

SurgeryPancreas CancerNeoadjuvant Chemotherapy+3 more
Sahlgrenska University Hospital432 enrolled1 locationNCT06714604